FIA
EVH icon

FNY Investment Advisers’s Evolent Health EVH Stock Holding History

FNY Investment Advisers’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27K Hold
5,000
– – 0.01% 494
2026
Q1 		$11K Hold
5,000
– – ﹤0.01% 536
2025
Q4 		$20K Sell
5,000
-17,632
-78% -$98K 0.01% 563
2025
Q3 		$191K Buy
+22,632
New +$220K 0.06% 277
2019
Q1 		– Sell
-550
Closed -$10K – 764
2018
Q4 		$10K Buy
+550
New +$12.7K ﹤0.01% 418

Other funds holding EVH

BSP
Benefit Street Partners New York $69.6M AUM
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
TWP
Tempus Wealth Planning Irvine, California $511M AUM 28.39% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
EFL
ERn Financial LLC Middleton, Wisconsin $604M AUM 19.83% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
WN
Williams & Novak Westlake Village, California $151M AUM 27.43% 1-Year Est. Return

FNY Investment Advisers's EVH Position: Q2 2026 in Review

FNY Investment Advisers held its Evolent Health (EVH) position steady in Q2 2026 at 5,000 shares worth $27K. The position accounts for 0.01% of the portfolio, ranked #494.

FNY Investment Advisers first reported a position in EVH in Q4 2018 and has held it in 5 quarters since. The position peaked at $191K in Q3 2025. 36 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • FNY Investment Advisers held 5,000 shares of Evolent Health worth $27K as of Q2 2026.
  • FNY Investment Advisers left its Evolent Health share count unchanged in Q2 2026.
  • Evolent Health made up 0.01% of FNY Investment Advisers's portfolio in Q2 2026, its #494 holding.
  • FNY Investment Advisers first reported a position in Evolent Health in Q4 2018 and has held it in 5 quarters since.
  • FNY Investment Advisers's Evolent Health position peaked at $191K in Q3 2025.
  • 36 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.